A case-cohort vaping study has two overlapping routes into its sample
Trace baseline subcohort selection and additional cases before reading a selected analysis file as a population denominator.
No Vape · Updated

Find the cohort behind the analysis file
The underlying cohort and the subset with detailed measurements are different groups. Locate when the subcohort was selected and which outcome determines case inclusion. Do not assume that everybody outside the subcohort is a non-case, or that a person selected at baseline cannot later experience the outcome.
O’Brien, Lawrence and Keil’s original methods paper describes cases and a baseline random subcohort, with possible overlap. Its original indexed methods passage and public figure caption support this introductory design distinction. We do not claim a full-paper clinical appraisal or import disease findings into vaping; this guide addresses how the analysis sample was assembled.
Draw two membership circles
One circle represents selected subcohort members. The other represents included outcome cases. Mark their possible overlap rather than adding the circle sizes as though every person appeared only once. Retain the report’s actual sampling description: case inclusion and detailed measurement can have further stated restrictions that a generic design label does not reveal.
In a fictional reading sketch, some adults chosen for a baseline subcohort later appear among the included cases. Other included cases were outside that original subset. The sketch illustrates two selection routes into the same analysis. It supplies no actual participant count, risk estimate, clinical condition or method for calculating an effect.
Do not rename the subcohort as a permanent control group
Baseline sampling does not guarantee future non-occurrence of the outcome. Calling every subcohort member a non-case would erase the overlapping membership the design permits. This is a different sampling structure from simply selecting a fixed set of cases and non-cases after outcome status is known.
Look for how the report’s analysis accounts for selection rather than treating an adjusted label as sufficient. Specialized methods may be required, and this introductory map does not prescribe them. Keep uncertainty, follow-up and measurement definitions with the reported association. A large analysis table does not make its case fraction a prevalence estimate for the full source population.
Retain the useful scope in your summary
Your note can identify the underlying cohort, the baseline subset and the additionally included cases, plus any overlap and sampling details that remain unclear. Distinguish the number of people in the source cohort from the number with the expensive or detailed measurement. Do not reconstruct an unreported full-cohort count by reversing a rounded percentage.
The design can make use of available research resources without automatically invalidating its findings or establishing every causal claim. A personal vaping record cannot supply missing sampling information. For health-related interpretation, bring the actual report to a qualified professional. The reading task is complete when selected membership no longer becomes an unsupported personal forecast or a false population rate.
Sources and scope
Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.
Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write